Asia's first AI-driven in vitro modelling system, CellXpress.ai, has been launched at the National Engineering Research Center for Biochips in Zhangjiang, Pudong, on August 11.
The platform enables high-throughput, industrial-scale production of high-fidelity 3D organoids, potentially cutting new drug development costs significantly.
The launch coincided with the establishment of the Intelligent Organoid Innovation and Industry Alliance and the Organoid and Organ-on-a-Chip Innovation R&D Center at the facility.
